Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126196591 | 12619659 | 1 | I | 20130404 | 20130606 | 20160803 | 20160803 | EXP | GB-PFIZER INC-1752006 | PFIZER | 68.00 | YR | F | Y | 94.00000 | KG | 20160803 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126196591 | 12619659 | 1 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, FREQ: 1 WEEK, INTERVAL: 3 | UNK | 71484 | 2 | MG | Q3W | ||||||
| 126196591 | 12619659 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 575 ML AT A CONCENTRATION OF 1.30 MG/ML, FREQ: 1 WEEK, INTERVAL: 3 | 0 | ||||||||||
| 126196591 | 12619659 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1500 MG, FREQ: 1 WEEK, INTERVAL:3 | 0 | 1500 | MG | Q3W | |||||||
| 126196591 | 12619659 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Intravenous (not otherwise specified) | 100 MG, FREQ: 1 WEEK, INTERVAL: 3 | 0 | 100 | MG | Q3W | |||||||
| 126196591 | 12619659 | 5 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
| 126196591 | 12619659 | 6 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | UNK | 0 | |||||||||||
| 126196591 | 12619659 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126196591 | 12619659 | 1 | B-cell lymphoma |
| 126196591 | 12619659 | 2 | B-cell lymphoma |
| 126196591 | 12619659 | 3 | B-cell lymphoma |
| 126196591 | 12619659 | 4 | B-cell lymphoma |
| 126196591 | 12619659 | 6 | Blood pressure measurement |
| 126196591 | 12619659 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126196591 | 12619659 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126196591 | 12619659 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126196591 | 12619659 | 1 | 20130322 | 0 | ||
| 126196591 | 12619659 | 2 | 20130312 | 0 | ||
| 126196591 | 12619659 | 3 | 20130322 | 0 | ||
| 126196591 | 12619659 | 4 | 20130322 | 0 |